Young Living and doTERRA distributors were reprimanded after the Food and Drug Administration FDA issued warning statements via overnight delivery to CEO Gary Young and David Stirling. Young Living and doTERRA both use independent distributors as a sales-force.
The majority of complaints the FDA issued in the warning letters involved the way some independent distributors marketed the companies’ products. Primarily, the FDA was concerned with Young Living and doTERRA consultants’ online marketing material for the brands’ essential oils.